These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5404977)

  • 1. [Relationship between the elevation of liver xanthine-oxidase, hyperuricemia and uricuria in gout].
    Ciccoli L; Riario-Sforza G; Marinello E; Marcolongo R; Carcassi A
    Reumatismo; 1969; 21(5):277-8. PubMed ID: 5404977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies of fructose overloading in normal subjects and in patients with gout].
    Bianco G; Di Paolo N; Lunghetti R; Bravi A
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):969-84. PubMed ID: 5760343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current biochemical acquisitions on pathogenesis of gout].
    Marcolongo R
    Reumatismo; 1971; 23(3):109-25. PubMed ID: 5150688
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of processing Phellodendron amurense with salt on anti-gout].
    Yang C; Zhu JX; Wang Y; Wen YL; Kong LD
    Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):145-8. PubMed ID: 15714822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of uric acid formation.
    N Engl J Med; 1968 Feb; 278(6):331-2. PubMed ID: 5638350
    [No Abstract]   [Full Text] [Related]  

  • 7. [Xanthine oxidase activity in the jejunal mucosa of patients with gout].
    Riario-Sforza G; Carcassi A; Bayeli PF; Marcolongo R; Marinello E; Montagnani M
    Boll Soc Ital Biol Sper; 1969 Jun; 45(12):785-6. PubMed ID: 5375171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of action and role of xanthine oxidoreductases (author's transl)].
    Jezewska MM
    Postepy Biochem; 1974; 20(3):259-79. PubMed ID: 4849147
    [No Abstract]   [Full Text] [Related]  

  • 9. Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.
    Bruce SP
    Ann Pharmacother; 2006 Dec; 40(12):2187-94. PubMed ID: 17132810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid and cardiovascular risk.
    Parmar MS
    N Engl J Med; 2009 Jan; 360(5):539; author reply 540-1. PubMed ID: 19186310
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia.
    Boss GR; Ragsdale RA; Zettner A; Seegmiller JE
    J Lab Clin Med; 1980 Nov; 96(5):783-9. PubMed ID: 6893465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver xanthine-oxidase in gout subjects].
    Marinello E; Riario-Sforza G; Ciccoli L; Carcassi A; Marcolongo R
    Reumatismo; 1969; 21(5):308-9. PubMed ID: 5404983
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
    Zhu JX; Wang Y; Kong LD; Yang C; Zhang X
    J Ethnopharmacol; 2004 Jul; 93(1):133-40. PubMed ID: 15182918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
    Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R; Vindel J; Lamarche M; Kissel P
    Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
    Rapado Errazti A
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):304-6. PubMed ID: 5997999
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperuricemia. 3. The miscible pool of uric acid, sources of uric acid, uricolysis and urinary elimination of uric acid].
    Ryckewaert A; Dry J; Paolaggi F
    Rev Rhum Mal Osteoartic; 1966; 33(1):39-46. PubMed ID: 5910833
    [No Abstract]   [Full Text] [Related]  

  • 18. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 19. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice.
    Kong LD; Yang C; Ge F; Wang HD; Guo YS
    J Ethnopharmacol; 2004 Aug; 93(2-3):325-30. PubMed ID: 15234772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the possible role of xanthine oxidase in the oxidation of glyoxylate to oxalate.
    Gibbs DA; Watts RW
    Clin Sci; 1966 Oct; 31(2):285-97. PubMed ID: 6005970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.